SCM Pharma Launches Testing Services

SCM Pharma, a UK-based fill/finish provider, has launched two new testing services to complement its sterile manufacturing capabilities and reduce the risks associated with offsite testing for client projects.

SCM has introduced Sterility and Bacterial Endotoxin Testing (BET) to its GMP-compliant facility, to supplement its existing analytical, stability and microbiological testing capabilities. Both methods are set to be rolled out for clients on a number of recently secured contracts by SCM Pharma following the full validation of both testing services.

Dianne Sharp, managing director at SCM Pharma, remarked, “The launch of these in-house testing services is a major milestone in the firm’s development in that it allows us to fill, test and release sterilized product for our clients all under one roof.”